| scholarly article | Q13442814 |
| P2093 | author name string | Joshua L Dunaief | |
| Benjamin J Kim | |||
| Daniel Sarezky | |||
| Aaishah R Raquib | |||
| P2860 | cites work | Direct and indirect antioxidant properties of α-lipoic acid and therapeutic potential. | Q38071998 |
| Geographic atrophy: clinical features and potential therapeutic approaches | Q38179138 | ||
| Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review. | Q38569263 | ||
| Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats | Q45161327 | ||
| Lipoic acid in multiple sclerosis: a pilot study | Q46407394 | ||
| Alpha-lipoic acid restores tear production in an animal model of dry eye. | Q46950481 | ||
| Impaired apparent ion demand in experimental diabetic retinopathy: correction by lipoic Acid | Q46979888 | ||
| Iron induced oxidative damage as a potential factor in age-related macular degeneration: the Cogan Lecture | Q48558289 | ||
| Effect of alpha-lipoic acid on the peripheral conversion of thyroxine to triiodothyronine and on serum lipid-, protein- and glucose levels | Q67888576 | ||
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 | Q24544001 | ||
| Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential | Q24658099 | ||
| Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration | Q28290149 | ||
| Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. | Q33502975 | ||
| Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling | Q33712137 | ||
| Systemic administration of the antioxidant/iron chelator α-lipoic acid protects against light-induced photoreceptor degeneration in the mouse retina | Q34230843 | ||
| Antioxidant supplements prevent oxidation of cysteine/cystine redox in patients with age-related macular degeneration | Q34479424 | ||
| Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. | Q34576734 | ||
| α-Lipoic acid antioxidant treatment limits glaucoma-related retinal ganglion cell death and dysfunction. | Q34766445 | ||
| The short-term effects of antioxidant and zinc supplements on oxidative stress biomarker levels in plasma: a pilot investigation | Q35981098 | ||
| Pharmacokinetic study of lipoic acid in multiple sclerosis: comparing mice and human pharmacokinetic parameters | Q36373827 | ||
| Lipoic acid decreases inflammation and confers neuroprotection in experimental autoimmune optic neuritis | Q37180260 | ||
| A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease | Q37456775 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1899-1903 | |
| P577 | publication date | 2016-09-29 | |
| P1433 | published in | Clinical Ophthalmology | Q5133782 |
| P1476 | title | Tolerability in the elderly population of high-dose alpha lipoic acid: a potential antioxidant therapy for the eye. | |
| P478 | volume | 10 |
Search more.